We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.12B
AUM Growth
-$54.3M
Cap. Flow
+$518K
Cap. Flow %
0.01%
Top 10 Hldgs %
6.44%
Holding
1,475
New
99
Increased
592
Reduced
300
Closed
114

Sector Composition

Rank Sector Weight
1 Financials 25.32%
2 Consumer Discretionary 11.88%
3 Industrials 11.76%
4 Technology 10.68%
5 Energy 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTH
1251
Faeth Therapeutics
FTH
$629M
$84.7K ﹤0.01%
5,645
DTIL icon
1252
Precision BioSciences
DTIL
$207M
$83.8K ﹤0.01%
8,180
OCC icon
1253
Optical Cable Corp
OCC
$143M
$82.5K ﹤0.01%
27,600
KFFB icon
1254
Kentucky First Federal Bancorp
KFFB
$44.9M
$82.2K ﹤0.01%
16,000
INAB icon
1255
IN8bio
INAB
$9.64M
$81.4K ﹤0.01%
2,610
+977
+60% +$36.6K
BIOR
1256
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$80.9K ﹤0.01%
3,728
+2,000
+116% +$64.1K
HYPD
1257
Hyperion DeFi Inc
HYPD
$40.9M
$79.5K ﹤0.01%
599
NNVC icon
1258
NanoViricides
NNVC
$36.2M
$79.1K ﹤0.01%
59,039
-35,000
-37% -$49.5K
STRR
1259
DELISTED
Star Equity Holdings
STRR
$78.4K ﹤0.01%
15,678
SVRA icon
1260
Savara
SVRA
$1.19B
$77.1K ﹤0.01%
20,400
-366,393
-95% -$1.31M
JRSH icon
1261
Jerash Holdings
JRSH
$63.5M
$77.1K ﹤0.01%
25,600
VIRX
1262
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$77K ﹤0.01%
74,000
-51,000
-41% -$69.2K
FREE
1263
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$77K ﹤0.01%
21,375
+1,738
+9% +$6.64K
SBEV icon
1264
Splash Beverage Group
SBEV
$2.72M
$75.1K ﹤0.01%
796
LTRPA
1265
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$73.3K ﹤0.01%
150,000
LOAN
1266
Manhattan Bridge Capital
LOAN
$47.1M
$73K ﹤0.01%
15,216
UAMY icon
1267
United States Antimony
UAMY
$1.02B
$72.1K ﹤0.01%
195,500
PFIN
1268
DELISTED
P&F Industries
PFIN
$69.8K ﹤0.01%
10,500
AWX icon
1269
Avalon Holdings
AWX
$10.1M
$68.9K ﹤0.01%
35,500
ALGS icon
1270
Aligos Therapeutics
ALGS
$34.9M
$68.7K ﹤0.01%
3,680
ANIX icon
1271
Anixa Biosciences
ANIX
$116M
$68.7K ﹤0.01%
21,000
BRLT icon
1272
Brilliant Earth
BRLT
$21.6M
$67.3K ﹤0.01%
22,800
-50,322
-69% -$181K
CVU icon
1273
CPI Aerostructures
CVU
$68.5M
$66.8K ﹤0.01%
+20,000
New +$73.7K
NTWK icon
1274
NetSol Technologies
NTWK
$50.6M
$65.8K ﹤0.01%
36,140
-45,256
-56% -$101K
MPU icon
1275
Mega Matrix
MPU
$13.7M
$65.5K ﹤0.01%
74,500

Similar funds

Bridgeway Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Bridgeway Capital Management held 1,475 positions worth $4.12B, down 1.3% from $4.18B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q3 2023 filing shows 99 new, 592 increased, 300 reduced and 114 closed positions. Its largest new stake was Vir Biotechnology: 1,345,635 shares worth $12.6M. The largest sale was Boise Cascade, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q3 2023 buy was Vir Biotechnology: 1,345,635 shares worth $12.6M.
  • Bridgeway Capital Management added most to Oracle in Q3 2023, an estimated $12.4M increase.
  • Bridgeway Capital Management's biggest Q3 2023 reduction was Boise Cascade, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Treehouse Foods in Q3 2023, selling an estimated $11.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.12B portfolio in Q3 2023.
  • Bridgeway Capital Management opened 99 new positions and closed 114 in Q3 2023.
  • Bridgeway Capital Management's portfolio value fell 1.3% quarter-over-quarter to $4.12B.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.